– Rapid real-time PCR test allows testing for SARS-CoV2 in only a few hours
– Test kit to be made available via Curetis’ European sales channels
– Synergies with Curetis Unyvero HPN panel for pneumonia testing for bacterial co-infections in Covid-19 patients
OpGen, Inc. (OPGN)
reported an update on the business of Curetis GmbH (“Curetis”), the
other party to the planned business combination with OpGen. Today,
Curetis announced that it started offering a CE-IVD certified real-time
PCR test kit for SARS-CoV2 (also known as 2019-nCov), the causal
pathogen of Corona Virus Disease 2019 (Covid-19). The test kit was
developed and is manufactured by Curetis’ strategic partner BGI
(Shenzhen, China) and was cleared by Chinese authorities in January
2020. In compliance with European regulations for in-vitro-diagnostics
(IVD) tests, the test kit was CE-IVD certified on February 28, 2020.
The
BGI 2019-nCoV RT-qPCR Kit enables diagnostic laboratories to perform
SARS-CoV2 testing of nasopharyngeal swabs and bronchoalveolar lavage
fluid of patients suspected to suffer from Covid-19. The test kit is
compatible with standard methods for extracting the virus’ nucleic acid
from the sample such as the QIAamp Viral RNA Mini Kit (QIAGEN) and can
be performed on standard real-time PCR instruments such as the Applied
Biosystems 7500 Real-Time PCR System (ThermoFisher Scientific) that are
available in many molecular diagnostic laboratories in Europe. The test
kit includes all necessary reagents and controls to test up to 48
patients in just a few hours.
The test will be made available to diagnostic laboratories in Europe through
Curetis network of distribution partners but – owing to the special circumstances of the global SARS-CoV2 outbreak – also directly by Curetis in countries where Curetis’ distribution partners are not set up to supply the test kit themselves at short notices.
https://finance.yahoo.com/news/opgen-provides-curetis-now-offering-113010764.html
Curetis network of distribution partners but – owing to the special circumstances of the global SARS-CoV2 outbreak – also directly by Curetis in countries where Curetis’ distribution partners are not set up to supply the test kit themselves at short notices.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.